{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:31:32Z","timestamp":1775482292355,"version":"3.50.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Infections and cancer are major causes of premature death in organ recipients. However, there have been few advances in personalized immunosuppressive therapy. We previously reported that a cell-based assay measuring CD14<jats:sup>+<\/jats:sup>16<jats:sup>+<\/jats:sup>tumor necrosis factor-\u03b1<jats:sup>+<\/jats:sup> monocytes after peripheral blood mononuclear cell (PBMC) incubation with Epstein-Barr virus peptides has a high sensitivity for detecting over-immunosuppression (OIS) events in kidney recipients in the short term. We aimed to develop a risk score for predicting long-term events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We studied 551 PBMC samples from 118 kidney recipients. Following random allocation to a testing and training set, we derived a risk function for the delineated tertiles of low, intermediate, and high risk of OIS based on age and CD14<jats:sup>+<\/jats:sup>16<jats:sup>+<\/jats:sup>tumor necrosis factor-\u03b1<jats:sup>+<\/jats:sup> cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Patients were followed for a median of 6.3 y (25th\u201375th percentiles: 3.7\u20138.3 y). Of these, 40 (34%) experienced an OIS event. The validation indicated that the risk score was well calibrated, with an absolute risk of 21%, 41%, and 61% in the low-, intermediate-, and high-risk categories, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.03). In sensitivity analyses, the risk score was robust to alternative definitions of OIS ranging from mild to severe. In particular, when restricted to life-threatening OIS, the proportion of events varied from 5% to 27% among the low- and high-risk categories, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Using a combination of age and in vitro PBMC response to Epstein-Barr virus peptides allows a substantial shift in the estimated risk of OIS events.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005279","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T14:00:18Z","timestamp":1734012018000},"page":"1191-1200","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A Risk Score Using a Cell-based Assay Predicts Long-term Over-immunosuppression Events in Kidney Transplant Recipients"],"prefix":"10.1097","volume":"109","author":[{"given":"Olivier","family":"D\u00e9sy","sequence":"first","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University Health Center (CHU) of Quebec Research Center, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pier","family":"Thivierge","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University Health Center (CHU) of Quebec Research Center, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"B\u00e9land","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University Health Center (CHU) of Quebec Research Center, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Simon","family":"Desgagn\u00e9s","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University Health Center (CHU) of Quebec Research Center, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Bouchard-Boivin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University Health Center (CHU) of Quebec Research Center, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alcino","family":"Gama","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University Health Center (CHU) of Quebec Research Center, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Houde","sequence":"additional","affiliation":[{"name":"Transplantation Unit, Renal Division, Department of Medicine, Faculty of Medicine, University Health Center of Quebec, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Lapointe","sequence":"additional","affiliation":[{"name":"Transplantation Unit, Renal Division, Department of Medicine, Faculty of Medicine, University Health Center of Quebec, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[{"name":"Transplantation Unit, Renal Division, Department of Medicine, Faculty of Medicine, University Health Center of Quebec, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Lesage","sequence":"additional","affiliation":[{"name":"Transplantation Unit, Renal Division, Department of Medicine, Faculty of Medicine, University Health Center of Quebec, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sacha A.","family":"De Serres","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University Health Center (CHU) of Quebec Research Center, Laval University, QC, Canada."},{"name":"Transplantation Unit, Renal Division, Department of Medicine, Faculty of Medicine, University Health Center of Quebec, Laval University, QC, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"R1-20250624","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation.","volume":"385","author":"Hariharan","year":"2021","journal-title":"N Engl J Med"},{"key":"R2-20250624","doi-asserted-by":"crossref","first-page":"151494","DOI":"10.1016\/j.semnephrol.2024.151494","article-title":"Epidemiology of cancer in kidney transplant recipients.","volume":"44","author":"Massicotte-Azarniouch","year":"2024","journal-title":"Semin Nephrol"},{"key":"R3-20250624","doi-asserted-by":"crossref","first-page":"151486","DOI":"10.1016\/j.semnephrol.2023.151486","article-title":"Diagnosis, prevention, and treatment of infections in kidney transplantation.","volume":"43","author":"Bharati","year":"2024","journal-title":"Semin Nephrol"},{"key":"R4-20250624","first-page":"1","article-title":"Mortality in the United States, 2021.","volume":"456","author":"Xu","year":"2022","journal-title":"NCHS Data Brief"},{"key":"R5-20250624","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2215\/CJN.14570920","article-title":"De Novo malignancies after kidney transplantation.","volume":"17","author":"Al-Adra","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"R6-20250624","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-6143.2004.00350.x","article-title":"Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS.","volume":"4","author":"Dharnidharka","year":"2004","journal-title":"Am J Transplant"},{"key":"R7-20250624","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10096-018-3405-5","article-title":"Single-center analysis of infectious complications in older adults during the first year after kidney transplantation.","volume":"38","author":"Hemmersbach-Miller","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R8-20250624","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1097\/TP.0000000000000842","article-title":"A rationale for age-adapted immunosuppression in organ transplantation.","volume":"99","author":"Krenzien","year":"2015","journal-title":"Transplantation"},{"key":"R9-20250624","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.trre.2015.08.001","article-title":"Need for optimized immunosuppression in elderly kidney transplant recipients.","volume":"29","author":"Lehner","year":"2015","journal-title":"Transplant Rev (Orlando)"},{"key":"R10-20250624","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1038\/cti.2014.3","article-title":"Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation.","volume":"3","author":"Fernandez-Ruiz","year":"2014","journal-title":"Clin Transl Immunol"},{"key":"R11-20250624","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajt.2023.10.031","article-title":"The Banff 2022 Kidney Meeting Work Plan: data-driven refinement of the Banff Classification for renal allografts.","volume":"24","author":"Roufosse","year":"2024","journal-title":"Am J Transplant"},{"key":"R12-20250624","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/ajt.16474","article-title":"Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation.","volume":"21","author":"Callemeyn","year":"2021","journal-title":"Am J Transplant"},{"key":"R13-20250624","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ki.2015.268","article-title":"Finding the safe place between the hammer and the anvil: sounding the depth of therapeutic immunosuppression.","volume":"88","author":"Thaunat","year":"2015","journal-title":"Kidney Int"},{"key":"R14-20250624","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1681\/ASN.2016080858","article-title":"Moving biomarkers toward clinical implementation in kidney transplantation.","volume":"28","author":"Menon","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R15-20250624","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1681\/ASN.2017010004","article-title":"Precision transplant medicine: biomarkers to the rescue.","volume":"29","author":"Naesens","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R16-20250624","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.4049\/jimmunol.2000782","article-title":"A sequential two-step cell-based assay predicts immunosuppression-related adverse events.","volume":"205","author":"Bouchard-Boivin","year":"2020","journal-title":"J Immunol"},{"key":"R17-20250624","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ekir.2019.07.007","article-title":"TNF-alpha production by monocytes stimulated with Epstein-Barr virus\u2014peptides as a marker of immunosuppression-related adverse events in kidney transplant recipients.","volume":"4","author":"Bouchard-Boivin","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R18-20250624","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/TP.0000000000002133","article-title":"Impaired secretion of TNF-alpha by monocytes stimulated with EBV peptides associates with infectious complications after kidney transplantation.","volume":"102","author":"Vallin","year":"2018","journal-title":"Transplantation"},{"key":"R19-20250624","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/TP.0000000000002132","article-title":"Sensing danger after kidney transplantation.","volume":"102","author":"Zecher","year":"2018","journal-title":"Transplantation"},{"key":"R20-20250624","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.ekir.2019.10.006","article-title":"A Test identifying biomarkers of immunosuppression-related adverse events in kidney transplant recipients.","volume":"4","author":"Legendre","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R21-20250624","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/clpt.2011.111","article-title":"Biomarkers of over-immunosuppression.","volume":"90","author":"Budde","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R22-20250624","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures.","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"R23-20250624","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","article-title":"Use and misuse of the receiver operating characteristic curve in risk prediction.","volume":"115","author":"Cook","year":"2007","journal-title":"Circulation"},{"key":"R24-20250624","doi-asserted-by":"crossref","first-page":"100486","DOI":"10.1016\/j.conctc.2019.100486","article-title":"Choosing primary endpoints for clinical trials of health care interventions.","volume":"16","author":"McLeod","year":"2019","journal-title":"Contemporary Clin Trials Commun"},{"key":"R25-20250624","author":"Silverstein"},{"key":"R26-20250624","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/jocn.13435","article-title":"Stressors and coping resources of Australian kidney transplant recipients related to medication taking: a qualitative study.","volume":"26","author":"Low","year":"2017","journal-title":"J Clin Nurs"},{"key":"R27-20250624","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.3390\/ijerph17165798","article-title":"The difficulties and needs of organ transplant recipients during postoperative care at home: a systematic review.","volume":"17","author":"Yang","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R28-20250624","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1097\/TP.0000000000005000","article-title":"Perioperative considerations in older kidney and liver transplant recipients: a review.","volume":"108","author":"Chanan","year":"2024","journal-title":"Transplantation"},{"key":"R29-20250624","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pds.5407","article-title":"Core concepts in pharmacoepidemiology: confounding by indication and the role of active comparators.","volume":"31","author":"Sendor","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R30-20250624","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40697-015-0061-x","article-title":"Developing renal allograft surveillance strategies\u2014urinary biomarkers of cellular rejection.","volume":"2","author":"Hirt-Minkowski","year":"2015","journal-title":"Can J Kidney Health Dis"},{"key":"R31-20250624","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41581-021-00428-0","article-title":"Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury.","volume":"17","author":"Oellerich","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R32-20250624","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/TP.0000000000005122","article-title":"Biomarkers in kidney transplantation: a rapidly evolving landscape.","volume":"109","author":"Gupta","year":"2025","journal-title":"Transplantation"},{"key":"R33-20250624","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/TP.0000000000005153","article-title":"The microscope and beyond: current trends in the characterization of kidney allograft rejection from tissue samples.","volume":"109","author":"Chaveau","year":"2025","journal-title":"Transplantation"},{"key":"R34-20250624","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1097\/TP.0000000000005136","article-title":"Unraveling renal transplant rejection: how can we measure intragraft cell-cell interactions?","volume":"108","author":"Cross","year":"2024","journal-title":"Transplantation"},{"key":"R35-20250624","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1097\/TP.0000000000005107","article-title":"Unveiling spatial immune cell profile in kidney allograft rejections using 36-plex immunofluorescence imaging.","volume":"108","author":"Hirai","year":"2024","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:00:44Z","timestamp":1750791644000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005279","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]}}}